Cloxacillin sodium

This classification denotes a penicillin antibiotic with the molecular formula C19H17ClN3O5S.Na.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 65LCB00B4Y, chemically known as 6-(((3-(2-chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but more generally known as cloxacillin sodium, which bears US NIH Compound Identifier 6098. European Medicines Agency schedules Cloxacillin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13400MIG. Most nations, for tariff and trade purposes, schedule cloxacillin sodium under HS 29411090 and SITC 54131. As of Q4 2014, CLOXACILLIN SODIUM remains US FDA's Preferred Term for this commodity. Cloxacillin sodium bears US NLM identifiers UMLS ID C0037496 and NCI Concept Code C47460. SMILES: CC1C(C(NO1)C2CCCCC2CL)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-].O.[NA+].